Publications by authors named "A C Barretto"

Article Synopsis
  • - Non-small cell lung cancer (NSCLC) accounts for 85% of lung cancer cases and is categorized into four progress stages; this study used Weighted Gene Co-expression Network Analysis (WGCNA) to understand its molecular mechanisms and find treatment targets.
  • - Eight preserved gene modules were identified, linked to key pathways like "Cell cycle" and "Pathways in cancer," with important genes such as PLK1, CDK1, EGFR, and the estrogen receptor ESR1 noted for their roles in tumor growth and survival outcomes.
  • - Analysis of drug repurposing highlighted potential therapeutic options, including GW-5074 and olomoucine, which target specific signaling processes, along with other candidates like pinoc
View Article and Find Full Text PDF

Objective: There is a substantial incidence of stroke in patients with atrial fibrillation (AF) not receiving anticoagulation. The reasons for not receiving anticoagulation are generally attributed to clinician's choice, however, a proportion of AF patients refuse anticoagulation. The aim of our study was to investigate factors associated with patient refusal of anticoagulation and the clinical outcomes in these patients.

View Article and Find Full Text PDF

Antioxidants are used to prevent oxidation reactions and inhibit the development of unwanted sensory characteristics that decrease the nutritional quality, acceptance, and shelf-life of processed meat products, improving their stability. Synthetic antioxidants, although efficient, are related to the development of diseases because they present toxic and carcinogenic effects. Thus, researchers and the meat industry are studying natural alternatives to synthetic antioxidants to be used in meat products, thus meeting the demand of consumers who seek foods without additives in their composition.

View Article and Find Full Text PDF

Unlabelled: Sacubitril/valsartan reduces mortality in patients with heart failure with reduced ejection fraction (HFrEF) when compared with enalapril. However, it is unknown the effect of both treatments on exercise capacity. We compared sacubitril/valsartan versus enalapril in patients with HFrEF based on peak oxygen consumption (VO) and 6-minute walk test (6-MWT).

View Article and Find Full Text PDF